Dolphin Neurostim is a pioneering company based in Toronto, Ontario, specializing in cutting-edge pain management solutions. The Dolphin Neurostim device is tailored to alleviate soft tissue pain by administering targeted DC micro-impulses known as MPS Therapy to specific neurological points. With a global reach extending to over 60,000 hospitals and pain clinics, this innovative approach effectively reduces nervous system stress, relaxes muscles, and provides natural pain relief.
At the core of the Dolphin Neurostim's offerings is MPS Therapy, a well-researched electrotherapy method that surpasses traditional techniques such as TENS, massage therapy, and acupuncture in producing superior pain relief outcomes. The company emphasizes the clinical efficacy of MPS Therapy in enhancing current practices and offers online courses and webinars for professionals seeking to integrate this powerful modality into their work.
With a strong focus on advancing pain management techniques, Dolphin Neurostim extends its expertise across various applications including scar release therapy, vagus nerve therapy, and concussion brain therapy. Backed by notable scientific findings showcasing significant reductions in cortisol levels, improved vagal tone, and enhanced pain relief, Dolphin Neurostim continues to empower practitioners and positively impact patient outcomes worldwide.
Generated from the website content